Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
170.11 MXN
252.23 B MXN
771.80 B MXN
1.96 B
About NOVARTIS N
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where NVS/N is featured.
Frequently Asked Questions
The current price of NVS/N is 2,138.50 MXN — it has decreased by −0.51% in the past 24 hours. Watch NOVARTIS AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange NOVARTIS AG stocks are traded under the ticker NVS/N.
We've gathered analysts' opinions on NOVARTIS AG future price: according to them, NVS/N price has a max estimate of 2,791.64 MXN and a min estimate of 1,952.57 MXN. Watch NVS/N chart and read a more detailed NOVARTIS AG stock forecast: see what analysts think of NOVARTIS AG and suggest that you do with its stocks.
NVS/N reached its all-time high on Oct 28, 2024 with the price of 2,237.37 MXN, and its all-time low was 454.91 MXN and was reached on Apr 17, 2009. View more price dynamics on NVS/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NVS/N stock is 0.00% volatile and has beta coefficient of 0.37. Track NOVARTIS AG stock price on the chart and check out the list of the most volatile stocks — is NOVARTIS AG there?
Today NOVARTIS AG has the market capitalization of 4.17 T, it has increased by 1.01% over the last week.
Yes, you can track NOVARTIS AG financials in yearly and quarterly reports right on TradingView.
NOVARTIS AG is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
NVS/N earnings for the last quarter are 40.59 MXN per share, whereas the estimation was 38.20 MXN resulting in a 6.27% surprise. The estimated earnings for the next quarter are 37.20 MXN per share. See more details about NOVARTIS AG earnings.
NOVARTIS AG revenue for the last quarter amounts to 252.66 B MXN, despite the estimated figure of 252.05 B MXN. In the next quarter, revenue is expected to reach 263.80 B MXN.
NVS/N net income for the last quarter is 62.83 B MXN, while the quarter before that showed 59.54 B MXN of net income which accounts for 5.54% change. Track more NOVARTIS AG financial stats to get the full picture.
Yes, NVS/N dividends are paid annually. The last dividend per share was 54.00 MXN. As of today, Dividend Yield (TTM)% is 3.05%. Tracking NOVARTIS AG dividends might help you take more informed decisions.
NOVARTIS AG dividend yield was 3.17% in 2023, and payout ratio reached 44.73%. The year before the numbers were 2.51% and 71.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 4, 2024, the company has 76.06 K employees. See our rating of the largest employees — is NOVARTIS AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS AG EBITDA is 402.43 B MXN, and current EBITDA margin is 44.33%. See more stats in NOVARTIS AG financial statements.
Like other stocks, NVS/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVARTIS AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVARTIS AG stock shows the buy signal. See more of NOVARTIS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.